Model
Edge
Ultragenyx Pharmaceutical Inc.
0001603347
Filing type
144
Filing date
Sep 14, 2026
Updated
Sep 15, 2026 ยท 2:33 PM
Copy reference
Filing
144
Notice of Proposed Sale of Securities